CNMD
CONMED Corporation
NYSEUSDEQUITY
Healthcare
DELAYED
Neutral
+10/100
Last price
44.48
▼ 2.85 (6.02%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
47.83
Prev close
47.33
Day high
48.25
Day low
44.31
Volume
456.37K
Market cap
$1.33B
P/E (TTM)
24.04
52W range
31.44 – 53.66
Day trading desk
Gap from prior close
+1.06%
Prior close 47.33
VWAP
44.94
-1.02% from price
Relative volume
2.05×
Unusually busy
Session range
8.89%
44.31 – 48.25
Position in range
4%
Near session low
ATR (14D)
1.57
3.52% of price
Prior day high
47.77
PDH
Prior day low
46.11
PDL
Bid / ask spread
—
Quote not published
Session volume
1.01M
Avg 492.92K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-4.73%
-6.7%
1M
-9.81%
-11.0%
3M
+32.42%
+27.9%
6M
+28.78%
+10.6%
YTD
+9.56%
-4.7%
1Y
-7.58%
-24.0%
3Y
-55.89%
-138.1%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CNMD open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
129.39K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 8, 26 | KELDERMAN KIM Director |
— | 500 | — | Direct |
| Jun 2, 26 | FARKAS CHARLES M Director |
— | 668 | — | Direct |
| Jun 2, 26 | KAYE MARK Director |
— | 668 | — | Direct |
| Jun 2, 26 | SCHWARZENTRAUB BARBARA J Director |
— | 668 | — | Direct |
| Jun 2, 26 | COUNCIL LAVERNE H. Director |
— | 668 | — | Direct |
| Jun 2, 26 | BRONSON DAVID M Director |
— | 668 | — | Direct |
| Mar 6, 26 | LALOMIA BRENT Officer |
— | 75 | — | Direct |
| Feb 24, 26 | KAYE MARK Director |
— | 152 | — | Direct |
| Nov 21, 25 | GLAZE RICHARD Chief Technology Officer |
SELL | 257 | $10.59K | Direct |
| Nov 20, 25 | GLAZE RICHARD Chief Technology Officer |
— | 375 | — | Direct |
| Nov 6, 25 | GARNER TODD W. Chief Financial Officer |
SELL | 3.50K | $150.50K | Direct |
| Nov 4, 25 | FOUST HOLLIE K General Counsel |
— | 4.00K | — | Direct |
| Oct 31, 25 | GARNER TODD W. Chief Financial Officer |
— | 7.50K | — | Direct |
| Sep 12, 25 | FARKAS CHARLES M Director |
SELL | 2.00K | $107.05K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ARONSON MARTHA GOLDBERG |
Director | 14.39K | Conversion of Exercise of derivative security |
BRONSON DAVID M |
Director | 17.91K | Conversion of Exercise of derivative security |
CONCANNON BRIAN P |
Director | 10.12K | Conversion of Exercise of derivative security |
COUNCIL LAVERNE H. |
Director | 4.72K | Conversion of Exercise of derivative security |
FARKAS CHARLES M |
Director | 15.53K | Conversion of Exercise of derivative security |
FOUST HOLLIE K |
General Counsel | 2.89K | Conversion of Exercise of derivative security |
HARTMAN CURT R |
Chief Executive Officer | 93.50K | Conversion of Exercise of derivative security |
SCHWARZENTRAUB BARBARA J |
Director | 6.45K | Conversion of Exercise of derivative security |
SHAGORY PETER K |
Officer | 3.90K | Conversion of Exercise of derivative security |
WORKMAN JOHN LEE |
Director | 20.89K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$1.33B
Enterprise value$2.13B
Revenue (TTM)$1.37B
Gross profit$762.31M
EBITDA$227.46M
Net income$56.50M
EPS (TTM)$1.85
Free cash flow$131.36M
Total cash$37.33M
Total debt$834.25M
Book value / share$34.73
Shares outstanding29.95M
Float29.66M
Short % of float8.48%
Dividend yield0.00%
Beta (5Y)0.94
Valuation & profitability ratios
Trailing P/E24.04
Forward P/E9.30
PEG ratio1.84
Price / sales—
Price / book1.28
EV / revenue1.55
EV / EBITDA9.36
Gross margin55.58%
Operating margin14.64%
Profit margin4.12%
Return on equity5.53%
Return on assets4.14%
Debt / equity80.11
Current ratio1.48
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.37B | $1.31B | $1.24B | $1.05B | +5.2% |
| Operating revenue | $1.37B | $1.31B | $1.24B | $1.05B | +5.2% |
| Cost of revenue | $624.25M | $573.98M | $568.50M | $474.23M | +8.8% |
| Gross profit | $750.48M | $733.03M | $676.25M | $571.25M | +2.4% |
| Research & development | $55.88M | $54.43M | $52.60M | $47.15M | +2.7% |
| Selling, general & admin | $591.97M | $478.28M | $503.04M | $454.04M | +23.8% |
| Total operating expense | $647.85M | $532.71M | $555.64M | $501.19M | +21.6% |
| Operating income | $102.62M | $200.33M | $120.60M | $70.05M | -48.8% |
| Net interest income | -$31.09M | -$37.30M | -$39.77M | -$28.91M | +16.7% |
| Pre-tax income | $71.12M | $163.03M | $80.83M | -$70.86M | -56.4% |
| Tax provision | $24.06M | $30.61M | $16.37M | $9.72M | -21.4% |
| Net income | $47.05M | $132.42M | $64.46M | -$80.58M | -64.5% |
| Net income to common | $47.05M | $132.42M | $64.46M | -$80.58M | -64.5% |
| Basic EPS | 1.52 | 4.29 | 2.10 | -2.68 | -64.6% |
| Diluted EPS | 1.51 | 4.25 | 2.04 | -2.68 | -64.5% |
| EBIT | $102.20M | $200.33M | $120.60M | -$41.96M | -49.0% |
| EBITDA | $176.49M | $272.18M | $192.48M | $27.56M | -35.2% |
| Basic shares | 31.04M | 30.85M | 30.67M | 30.04M | +0.6% |
| Diluted shares | 31.15M | 31.15M | 31.55M | 30.04M | -0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $40.82M | $24.46M | $24.30M | $28.94M | +66.9% |
| Cash & short-term investments | $40.82M | $24.46M | $24.30M | $28.94M | +66.9% |
| Accounts receivable | $247.83M | $237.73M | $242.28M | $191.34M | +4.2% |
| Inventory | $355.54M | $346.72M | $318.32M | $332.32M | +2.5% |
| Total current assets | $672.86M | $640.01M | $615.65M | $581.23M | +5.1% |
| Property, plant & equipment | $113.33M | $115.79M | $120.72M | $115.61M | -2.1% |
| Goodwill & intangibles | $1.39B | $1.42B | $1.46B | $1.50B | -2.4% |
| Total assets | $2.33B | $2.31B | $2.30B | $2.30B | +0.8% |
| Total current liabilities | $315.04M | $278.13M | $310.73M | $296.55M | +13.3% |
| Current debt | $712.00K | $715.00K | $708.00K | $69.75M | -0.4% |
| Long-term debt | $834.23M | $905.07M | $973.14M | $985.08M | -7.8% |
| Total debt | $834.94M | $905.78M | $973.85M | $1.05B | -7.8% |
| Total liabilities | $1.29B | $1.34B | $1.47B | $1.55B | -3.8% |
| Retained earnings | $588.77M | $560.28M | $452.53M | $412.63M | +5.1% |
| Shareholder equity | $1.03B | $962.68M | $834.22M | $745.54M | +7.3% |
| Working capital | $357.82M | $361.88M | $304.92M | $284.67M | -1.1% |
| Net tangible assets | -$355.96M | -$460.34M | -$622.11M | -$751.68M | +22.7% |
| Shares issued | 31.30M | 31.30M | 31.30M | 31.30M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $47.05M | $132.42M | $64.46M | -$80.58M | -64.5% |
| Depreciation & amortisation | $74.28M | $71.86M | $71.87M | $69.52M | +3.4% |
| Stock-based compensation | $28.32M | $25.56M | $24.26M | $21.73M | +10.8% |
| Change in working capital | -$11.45M | -$39.72M | -$39.58M | -$90.70M | +71.2% |
| Operating cash flow | $170.69M | $166.97M | $125.35M | $33.37M | +2.2% |
| Capital expenditure | -$19.81M | -$13.08M | -$19.03M | -$21.79M | -51.4% |
| Investing cash flow | -$20.96M | -$13.08M | -$20.03M | -$249.53M | -60.2% |
| Dividends paid | -$24.75M | -$24.65M | -$24.50M | -$23.96M | -0.4% |
| Financing cash flow | -$135.82M | -$151.00M | -$110.43M | $225.00M | +10.1% |
| Free cash flow | $150.88M | $153.88M | $106.32M | $11.58M | -2.0% |
| End cash position | $40.82M | $24.46M | $24.30M | $28.94M | +66.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $343.49M | $317.05M | $373.20M | $337.93M | $342.35M | +8.3% |
| Operating revenue | $343.49M | $317.05M | $373.20M | $337.93M | $342.35M | +8.3% |
| Cost of revenue | $146.03M | $133.60M | $154.91M | $171.81M | $154.03M | +9.3% |
| Gross profit | $197.46M | $183.45M | $218.28M | $166.12M | $188.32M | +7.6% |
| Research & development | $15.50M | $16.33M | $14.90M | $13.90M | $14.14M | -5.1% |
| Selling, general & admin | $145.55M | $141.70M | $166.76M | $140.34M | $136.02M | +2.7% |
| Total operating expense | $161.05M | $158.03M | $181.66M | $154.24M | $150.16M | +1.9% |
| Operating income | $36.41M | $25.41M | $36.62M | $11.88M | $38.16M | +43.2% |
| Net interest income | -$7.88M | -$7.06M | -$7.37M | -$7.61M | -$7.82M | -11.7% |
| Pre-tax income | $31.35M | $18.36M | $29.25M | $4.27M | $29.92M | +70.8% |
| Tax provision | $8.28M | $4.53M | $12.51M | $1.41M | $8.50M | +82.8% |
| Net income | $23.07M | $13.83M | $16.74M | $2.86M | $21.42M | +66.8% |
| Net income to common | $23.07M | $13.83M | $16.74M | $2.86M | $21.42M | +66.8% |
| Basic EPS | 0.77 | 0.45 | 0.54 | 0.09 | 0.69 | +71.1% |
| Diluted EPS | 0.77 | 0.45 | 0.54 | 0.09 | 0.69 | +71.1% |
| EBIT | $39.23M | $25.41M | $36.62M | $11.88M | $37.74M | +54.4% |
| EBITDA | $58.28M | $44.25M | $55.47M | $30.49M | $56.31M | +31.7% |
| Basic shares | 30.07M | 30.59M | 30.97M | 30.95M | 30.95M | -1.7% |
| Diluted shares | 30.12M | 30.62M | 31.03M | 31.05M | 31.05M | -1.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $37.33M | $35.03M | $40.82M | $38.93M | $33.94M | +6.6% |
| Cash & short-term investments | $37.33M | $35.03M | $40.82M | $38.93M | $33.94M | +6.6% |
| Accounts receivable | $239.77M | $228.66M | $247.83M | $224.94M | $234.15M | +4.9% |
| Inventory | $360.18M | $366.11M | $355.54M | $364.36M | $362.25M | -1.6% |
| Total current assets | $675.66M | $670.59M | $672.86M | $662.16M | $657.78M | +0.8% |
| Property, plant & equipment | $110.14M | $111.96M | $113.33M | $112.04M | $116.86M | -1.6% |
| Goodwill & intangibles | $1.36B | $1.38B | $1.39B | $1.40B | $1.41B | -1.4% |
| Total assets | $2.30B | $2.31B | $2.33B | $2.32B | $2.33B | -0.6% |
| Total current liabilities | $455.40M | $292.72M | $315.04M | $314.70M | $294.84M | +55.6% |
| Current debt | $177.20M | $711.00K | $712.00K | $746.00K | $714.00K | +24,822.5% |
| Long-term debt | $657.05M | $860.16M | $834.23M | $853.01M | $881.11M | -23.6% |
| Total debt | $834.25M | $860.87M | $834.94M | $853.75M | $881.83M | -3.1% |
| Total liabilities | $1.26B | $1.30B | $1.29B | $1.31B | $1.33B | -3.0% |
| Retained earnings | $625.66M | $602.59M | $588.77M | $572.03M | $575.36M | +3.8% |
| Shareholder equity | $1.04B | $1.02B | $1.03B | $1.01B | $1.00B | +2.3% |
| Working capital | $220.27M | $377.88M | $357.82M | $347.46M | $362.94M | -41.7% |
| Net tangible assets | -$319.93M | -$362.99M | -$355.96M | -$391.76M | -$405.87M | +11.9% |
| Shares issued | 30.14M | 31.30M | 31.30M | 31.30M | 31.30M | -3.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $23.07M | $13.83M | $16.74M | $2.86M | $21.42M | — | +66.8% |
| Depreciation & amortisation | $19.05M | $18.84M | $18.85M | $18.61M | $18.57M | — | +1.1% |
| Stock-based compensation | $5.23M | $5.50M | $4.97M | $4.59M | $4.90M | — | -4.9% |
| Change in working capital | -$11.15M | -$24.31M | -$16.02M | $21.33M | -$17.40M | — | +54.1% |
| Operating cash flow | $37.09M | $13.47M | $46.34M | $53.69M | $29.13M | — | +175.3% |
| Capital expenditure | -$2.93M | -$2.89M | -$5.11M | -$5.19M | -$5.73M | — | -1.5% |
| Investing cash flow | $11.57M | $4.11M | -$7.11M | -$5.19M | -$5.73M | — | +181.5% |
| Share buybacks | -$6.20M | -$37.02M | — | — | $0 | $0 | +83.2% |
| Dividends paid | $0 | $0 | -$6.19M | -$6.19M | -$6.19M | — | — |
| Financing cash flow | -$46.23M | -$22.55M | -$37.37M | -$43.52M | -$26.53M | — | -105.0% |
| Free cash flow | $34.16M | $10.58M | $41.22M | $48.50M | $23.41M | — | +222.9% |
| End cash position | $37.33M | $35.03M | $40.82M | $38.93M | $33.94M | — | +6.6% |
Options analytics
Put / call volume
0.50
Call-heavy session
Put / call open interest
0.14
Positioning, not flow
Max pain
45.00
+1.2% from spot
ATM implied vol
93.3%
Nearest strike to spot
Skew (10% OTM)
+7.3%
Puts bid over calls
Call volume
2
Contracts, this expiry
Put volume
1
Contracts, this expiry
Heaviest call OI
50.00
610 contracts
Heaviest put OI
45.00
106 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.11 | 1.38 | +24.3% |
| Mar 2026 | 0.82 | 0.89 | +8.8% |
| Dec 2025 | 1.32 | 1.43 | +8.0% |
| Sep 2025 | 1.05 | 1.08 | +2.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 1.00 | 7 | $336.33M | -0.5% |
| Next quarter | 1.27 | 7 | $368.99M | -1.1% |
| Current year | 4.54 | 7 | $1.37B | -0.6% |
| Next year | 4.78 | 7 | $1.43B | +4.9% |
Analyst targets & ownership
Mean target$45.50
High target$49.00
Low target$43.00
Implied upside2.29%
Analyst count6
ConsensusNONE
Strong buy / Buy0 / 0
Hold6
Sell / Strong sell0 / 1
Held by insiders0.43%
Held by institutions116.67%
Institutions holding344
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
45.98
-3.27% from price
SMA 20
46.10
-3.52% from price
SMA 50
48.03
-7.38% from price
SMA 100
42.36
+5.00% from price
SMA 200
40.97
+8.57% from price
EMA 12
46.11
-3.54% from price
EMA 26
46.57
-4.49% from price
EMA 50
46.06
-3.42% from price
RSI (14)
39.6
Neutral
MACD (12,26,9)
-0.46
Hist -0.01
ATR (14)
1.57
3.52% of price
Realised vol 30D
30.2%
Annualised
Bollinger upper
47.59
20, 2σ
Bollinger lower
44.62
20, 2σ
50 / 200 cross
Golden
48.03 vs 40.97
Trend bias
Above 200
+8.57%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.87
Less volatile than market
Correlation to SPY
0.25
Largely independent
Realised vol 30D
30.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-34.2%
Peak to trough
Max drawdown 5Y
-79.6%
Peak to trough
ATR 14
1.57
3.52% of price
Beta (reported)
0.94
5Y monthly, from filing
Short interest
Shares short
2.14M
Prior 2.32M
Change vs prior
-7.9%
Shorts covering
% of float
8.48%
Normal
% of shares out
7.14%
Against total outstanding
Days to cover
7.0
Crowded exit
Float
29.66M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 30, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Jul 30, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Jul 9, 26 | BMO Capital | INITIATED | — | Market Perform |
| Jun 29, 26 | B of A Securities | DOWNGRADE | Neutral | Underperform |
| May 18, 26 | B of A Securities | MAINTAINED | Neutral | Neutral |
| May 1, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Apr 30, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Mar 17, 26 | Piper Sandler | DOWNGRADE | Overweight | Neutral |
| Jan 29, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Jan 29, 26 | Needham | MAINTAINED | Hold | Hold |
| Dec 8, 25 | B of A Securities | MAINTAINED | Neutral | Neutral |
| Nov 6, 25 | JP Morgan | MAINTAINED | Neutral | Neutral |
Dividends & splits
Forward rate$0.80 / yr
Forward yield0.00%
5-year avg yield0.88%
Payout ratio10.81%
Ex-dividend dateSep 15, 2025
Next pay dateOct 3, 2025
Last split3:2
Split dateSep 10, 2001
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-06-17
Annual report of employee stock purchase
11-K · 2026-06-16
Corporate Changes & Voting Matters
8-K · 2026-06-04
Corporate Changes & Voting Matters
8-K · 2026-06-01
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-28
Corporate Changes & Voting Matters
8-K · 2026-05-20
Periodic Financial Reports
10-Q · 2026-04-30
Headlines
Surgical Equipment & Consumables - Diversified Stocks Q2 Recap: Benchmarking CONMED (NYSE:CNMD)
StockStory · 4d ago
CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026
Business Wire · 5d ago
3 Value Stocks That Concern Us
StockStory · 13d ago
Avantor Names Todd Garner as CFO
MT Newswires · 16d ago
1 Unpopular Stock That Should Get More Attention and 2 We Turn Down
StockStory · 19d ago
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
Zacks · 20d ago
Is Cardinal Health Building a New Tech-Enabled Healthcare Platform?
Zacks · 28d ago
Why Is Henry Schein (HSIC) Up 0.9% Since Last Earnings Report?
Zacks · 33d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.